Cite
APA Citation
Del Bello, A., Divard, G., Belliere, J., Congy‐Jolivet, N., Lanfranco, L., Ricard, R., Delas, A., Colombat, M., Esposito, L., Hebral, A., Cointault, O., Lefaucheur, C., Loupy, A., & Kamar, N. (2019). anti‐IL‐2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid‐term outcomes after ABO‐incompatible kidney transplantation. Clinical transplantation, 33(10), n/a. http://access.bl.uk/ark:/81055/vdc_100093292332.0x000037